Literature DB >> 26381328

Persistent high fever for more than 10 days during acute phase is a risk factor for endothelial dysfunction in children with a history of Kawasaki disease.

Yasuhiko Mori1, Hiroshi Katayama2, Kanta Kishi3, Noriyasu Ozaki3, Tatsuo Shimizu4, Hiroshi Tamai3.   

Abstract

BACKGROUND: Endothelial dysfunction has previously been reported in children with a history of Kawasaki disease, but the determinants of endothelial function in Kawasaki disease patients are still unknown. In this study, we investigated endothelial function in Kawasaki disease patients and attempted to identify risk factors for persistent endothelial dysfunction.
METHODS: Using high-resolution ultrasound, we measured the percent flow-mediated dilatation, an arterial response to reactive hyperemia, to evaluate endothelial function in 67 patients with a history of Kawasaki disease and 28 age- and sex-matched control subjects. We divided the Kawasaki disease patients into a group with impaired endothelial function (the percent flow-mediated dilatation below -2 standard deviations of the control group) and a group with normal endothelial function (the percent flow-mediated dilatation more than -2 standard deviations of control). Logistic multiple regression analysis was performed to identify independent predictors of impaired endothelial function.
RESULTS: In Kawasaki disease patients, the percent flow-mediated dilatation was significantly lower than in the control subjects (9.8±3.6%, compared with 13.1±3.4%, p<0.01). In 13 Kawasaki disease patients (3 patients with coronary artery lesions and 10 patients without coronary artery lesions), the percent flow-mediated dilatation was below -2 standard deviations of control. Logistic multiple regression analysis showed that a febrile period of longer than 10 days during the acute phase was the significant risk factor for endothelial dysfunction (odds ratio: 8.562; 95% confidence interval: 1.366-53.68). Presence of coronary artery lesions was not a determinant of endothelial dysfunction.
CONCLUSIONS: Systemic endothelial dysfunction exists in children with a history of Kawasaki disease, and a febrile period of longer than 10 days during the acute phase is an independent predictor of endothelial dysfunction irrespective of coronary artery involvement.
Copyright © 2015 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Coronary artery lesion; Endothelial function; Kawasaki disease; Percent flow-mediated dilatation; Vasculitis

Mesh:

Year:  2015        PMID: 26381328     DOI: 10.1016/j.jjcc.2015.08.008

Source DB:  PubMed          Journal:  J Cardiol        ISSN: 0914-5087            Impact factor:   3.159


  5 in total

1.  Oxidised Low-Density Lipoprotein and Its Receptor-Mediated Endothelial Dysfunction Are Associated with Coronary Artery Lesions in Kawasaki Disease.

Authors:  Yue-E He; Hui-Xian Qiu; Rong-Zhou Wu; Xing Rong; Hai-Tang Xu; Ru-Lian Xiang; Mao-Ping Chu
Journal:  J Cardiovasc Transl Res       Date:  2019-08-19       Impact factor: 4.132

2.  Ultrasound evaluation of endothelial dysfunction in immunoglobulin-resistant children with acute Kawasaki disease.

Authors:  Yizhou Wen; Yanfeng Yang; Yang Wen; Jimei Xi; Tingting Chen; Yaheng Lu; Li Wang; Yiling Liu; Feifei Si
Journal:  Clin Rheumatol       Date:  2022-08-18       Impact factor: 3.650

Review 3.  Recent updates on echocardiography and ultrasound for Kawasaki disease: beyond the coronary artery.

Authors:  Nobutaka Noto; Akiko Komori; Mamoru Ayusawa; Shori Takahashi
Journal:  Cardiovasc Diagn Ther       Date:  2018-02

4.  The radial augmentation index in children with Kawasaki disease without acute coronary artery lesions during the convalescent period.

Authors:  Jianbo Zheng; Tsuneyuki Nakamura; Na Lu; Kaori Hori; Masato Oguri; Masaru Sakurai; Masao Ishizaki
Journal:  Ther Clin Risk Manag       Date:  2019-06-12       Impact factor: 2.423

Review 5.  Molecular mechanisms of endothelial dysfunction in Kawasaki-disease-associated vasculitis.

Authors:  Yu Qiu; Yulin Zhang; Yifei Li; Yimin Hua; Yue Zhang
Journal:  Front Cardiovasc Med       Date:  2022-08-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.